Topical NMN for Hair Regrowth - Quick Reference Sheet
evipedia.ai
← Back

Topical NMN for Hair Regrowth

Created on 09/26/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Scalp-applied nicotinamide mononucleotide is a vitamin B3–derived compound used for thinning hair, aiming to recharge a cellular energy molecule that declines with age. The case rests on laboratory cells and mice; human signals involve related compounds or oral use, without independent confirmation. Scalp use appears gentle; the main practical risk is time lost while proven hair-loss treatments are set aside. It remains a laboratory idea, not a demonstrated treatment. (Full Review)

Protocol

Standard protocol
0.5% NMN daily (mice only)
No clinician or clinic has published a topical NMN hair protocol; serums often combine NMN with other actives at undisclosed concentrations
Application and timing
Once or twice daily
To dry scalp, by analogy with other leave-on hair products; evening allows longer contact; no timing study exists
Competing approaches
Topical alone or as add-on
Topical NMN alone or added to minoxidil or finasteride, or oral NMN (500 mg/day in the only human hair study); none has comparative human data
Time to effect
Human hair studies
12–24 weeks
Duration of the human NAD+ precursor hair studies
Response assessment
3–6 months
Hair-growth studies typically assess response only after 3–6 months of consistent use
Non-response
6 months
Unchanged photographs at 6 months indicate non-response

Benefits

Contraindications
  • Pregnant or breastfeeding women
  • People under 18 years of age
  • People with active scalp dermatitis, psoriasis flares, open wounds, or infection
  • People with active cancer or cancer treatment within the past 12 months, especially on PARP inhibitors, unless cleared by their oncologist
  • People with known hypersensitivity to NMN or other product ingredients
    •
Key Interactions
  • Topical minoxidil (prescription or over-the-counter): may increase irritation
  • 5-alpha-reductase inhibitors (finasteride, dutasteride): theoretical additive androgen-pathway effect
  • Topical retinoids (tretinoin, adapalene): increased irritation and NMN absorption
  • Over-the-counter salicylic acid or ketoconazole shampoos: increased scalp sensitivity
  • Oral NAD+ precursor supplements (NMN, nicotinamide riboside, niacin): additive NAD+ load
  • Other topical NAD+ boosters (niacinamide serums): additive NAD+ supply
  • Microneedling: greatly increases NMN delivery and irritation or infection risk
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Scalp irritation, redness, or itching; systemic effects from absorbed NMN; hair shedding; delayed use of proven hair-loss treatments
    •
  • Speculative: Amplified inflammation from aged cells; reduced pigment production
    •

Monitoring

Marker Target Why
Ferritin 50–100 ng/mL for hair growth Low iron stores cause shedding
TSH (thyroid-stimulating hormone) 0.5–2.5 mIU/L Thyroid disorders cause diffuse thinning
25-hydroxyvitamin D 40–60 ng/mL Deficiency is linked to hair loss
Hair density (phototrichogram) No established target; track change from own baseline Direct measure of regrowth
Hair shaft diameter (trichoscopy) No established target; track change from own baseline Detects thickening before density changes

Cadence: Baseline, then photographs and hair counts at 3 and 6 months and every 6–12 months while use continues; blood tests repeated every 6–12 months only if abnormal or shedding worsens

Qualitative Assessment

  • Hair shed on the pillow and during washing
  • Visible scalp through the part line
  • Hair volume, gloss, and ease of styling
  • Scalp comfort (itching, redness, flaking)
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.